JoelMartinCharrowMD
Medical Genetics • Chicago, ILClinical Biochemical Genetics, Clinical Genetics
Professor in Pediatrics, Northwestern University Medical School
Are you Dr. Charrow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ann Robert H Lurie Childrens Hospital of Chicago 59
225 E Chicago Ave
Chicago, IL 60611Phone+1 312-227-6120Fax+1 312-227-9413
Summary
- Dr. Joel Charrow, MD is a board certified medical geneticist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1976 - 1981
Icahn School of Medicine at Mount SinaiClass of 1976
Certifications & Licensure
IL State Medical License 1977 - 2026- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Open-Label Phase 3 Long-Term Safety Study of Migalastat Start of enrollment: 2011 Oct 14
- Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease Start of enrollment: 2015 Mar 14
Publications & Presentations
PubMed
- 33 citationsRisk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Reg...Robert J. Hopkin, Gustavo Cabrera, Joel Charrow, Roberta Lemay, Ana Maria Martins
Molecular Genetics and Metabolism. 2016-09-01 - 10 citationsLifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into AdulthoodSally E. Jensen, Zabin S. Patel, Robert Listernick, Joel Charrow, Jin Shei Lai
Journal of Clinical Psychology in Medical Settings. 2019-09-01 - 320 citationsSustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.Dominique P. Germain, Stephen Waldek, Maryam Banikazemi, David A. Bushinsky, Joel Charrow
Journal of the American Society of Nephrology. 2007-05-01
Press Mentions
Children with Achondroplasia Could Increase Bone Growth with Novel DrugOctober 27th, 2020
Experimental Drug Can Encourage Bone Growth in Children with DwarfismJune 18th, 2019
Professional Memberships
- Fellow
